FDA Approved Labcorp Diagnostic for Advanced Melanoma
On Aug. 10, 2026, Labcorp announced that the U.S. Food and Drug Administration (FDA) had approved Labcorp’s PGDx elio®…
-
-
Diagnostics | Disease | Medical Device | Medicine | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics | U.S. Congress | Women's Health
American Cancer Society Reports a Milestone 70 Percent 5-Year Survival Rate for all Cancers Combined
On Jan. 13, 2026, The American Cancer Society (ACS) released Cancer Statistics, 2026, the organization’s annual report on cancer facts and trends. The findings show, for…
-
Researchers design cancer vaccine blueprint for melanoma
On Jul. 24, 2025, University of Alberta (UA) researchers announced they have harnessed the power of artificial intelligence…
-
Biotechnology | Disease | Medicine | Oncology | Therapeutics
UK Nice leads the way in approving breakthrough treatment for multiple myeloma
On Jun. 13, 2025, people in England will become the first in the world to receive belantamab mafodotin…
-
study found genetic variant for hair graying, susceptibility to skin melanoma in horses
On Sep. 4, 2024, an international consortium led by scientists from Uppsala University in Sweden reported that the…
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Radiology | Therapeutics | Women's Health
NCI’s Cancer Trends Progress Report announced 2023 Incidence and Mortality Data
On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…
-
Molecular jackhammers’ ‘good vibrations’ eradicate cancer cells
On Dec. 19, 2023, a research team led by Rice University reported they found that the atoms of…
-
Oregon Health Sciences University dermatologists detected the world’s smallest skin cancer
On May 1, 2023, an Oregon Health Sciences University (OHSU) dermatologist and a multi-disciplinary team confirmed that a…
-
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
U.S. Preventive Services Task Force issued recommendation on screening for skin cancer
On Apr. 18, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening for…
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Radiology | Therapeutics | Women's Health
Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rate
On Jul. 8, 2021, the National Institutes of Health (NIH) reported that overall cancer death rates continue to…
-
AIM ImmunoTech announced NCI award of $14.54 million to study Ampligen as part of five Roswell Park-led chemokine modulation clinical trials in melanoma, colorectal and ovarian cancers
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
-
UArizona Cancer Center received $69M grant forsSkin cancer prevention study
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
-
Masonic Cancer Center researcher Dr. Liang Liu received skin cancer research grant
On Mar. 13, 2019, Dr. Liang Lie of Mason Cancer Center’s Hormel Institute received a $100,000 two year…
-
Genentech drug Cotellic (cobimetinib) was approved
On Nov. 10, 2015, Genentech announed that its drug Cotellic (cobimetinib) was approved by the U.S. Food and…
-
Treatment outcomes in black and white children with cancer was published
On Apr. 30, 2012, “Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database…
-
Biotechnology | Diagnostics | Disease | Medicine | Non-Profit Research | Oncology | Therapeutics | Women's Health
The University of Minnesota Masonic Children’s Hospital opened a new, innovative building for mothers and children
On Apr. 30, 2011, The University of Minnesota Masonic Children’s Hospital opened a new, innovative building for mothers…
-
Smilow Cancer Hospital opened for patient care
On Oct. 26, 2009, the Smilow Cancer Hospital opened for patient care with María Rosa Menocal, a Yale…
-
Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
-
National Cancer Institute researchers developed a new model for estimating the 5-year risk of melanoma
On Sept. 1, 2006, National Cancer Institute (NCI) researchers developed a new model for estimating the 5-year risk…
-
Biotechnology | Diagnostics | NIH | Oncology
The National Cancer Institute scientists identified an inherited gene that strongly affects risk for the most common form of melanoma
On Jun. 29, 2006, researchers at the National Cancer Institute (NCI), part of the National Institutes of Health,…
-
Biotechnology | HIV | NIH | Oncology
National Cancer Institute researchers replace a patient’s immune system with cancer-fighting cells
On Sept. 19, 2002, a new approach to cancer treatment that replaced a patient’s immune system with cancer-fighting…
-
Dr. Steven A Rosenberg conducted the first human gene transfer trial
On May 22, 1989, Dr. Steven A. Rosenberg and his team at the National Cancer Institute (NCI) performed…
-
Diagnostics | NIH | Oncology | Therapeutics
The Cold Spring Harbor Laboratory Cancer Center received NCI designation
In 1987, The Cold Spring Harbor Laboratory (CSHL) Cancer Center received National Cancer Institute (NCI) designation. CSHL researchers…
-
Biotechnology | FDA | Oncology | Therapeutics
Interferon became the first anticancer drug produced through biotechnology
On Jun. 5, 1986, the U.S. Food and Drug Administration (FDA) approved Hoffmann La Roche’s Interferon initially for…
